Fort Wayne Medical Institute

Recent papers from Fort Wayne Medical Institute

1. Prolonged Severe Hyperglycemia Requiring High-Dose Insulin After COVID-19 in a Patient with Type 2 Diabetes and Recent Long-Term Marijuana Cessation: A Case ReportThe Open COVID Journal · 2026
2. Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)The Lancet Regional Health - Americas · 2026
3. Pharmacist-Led Transitions of Care Reduced Hospital Readmission Rates for Medicare and Medicaid Patients2025
4. Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trialBlood Neoplasia · 2026
5. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJournal of the American College of Cardiology · 2004
6. Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung CancerTargeted Oncology · 2025
7. Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung CancerTargeted Oncology · 2025
8. SARS-CoV-2 Serological Surveillance of Both Vaccinated and Unvaccinated Zoo Animals with the Identification of a Sloth Bear and a Tapir with Previous InfectionViruses · 2025
9. High-fidelity 3D models of human cadavers and their organs with the use of handheld scanner–Alternative method in medical education and clinical practiceFrontiers in Medicine · 2025
10. A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trialFrontiers in Medicine · 2025
11. Health Assessment of Golden-Mantled Howler Monkeys (Alouatta Palliata Palliata) in Dry Forest From the North Pacific Coast, Costa RicaJournal of Zoo and Wildlife Medicine · 2025
12. ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia VeraActa Haematologica · 2025
13. The Impact of a Concomitant Meniscus Surgery on Hop Performance Symmetry in Patients Rehabilitating After Anterior Cruciate Ligament ReconstructionInternational Journal of Sports Physical Therapy · 2025
14. Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03Journal of Thoracic Oncology · 2025
15. Optimizing Clinical Trial Subject Selection: Insights from Exigent Research Network and the Tempus AI TIME Program CollaborationAI in Precision Oncology · 2024
16. Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and AzacitidineBlood · 2024
17. Evaluation of the Physiological and Psychological Impact of Ballet Performances Across Age Cohorts: An Observational Uncontrolled Case StudyJournal of Dance Medicine & Science · 2024
18. VELOCITY-Lung substudy-03: A phase 2 study of neoadjuvant domvanalimab (dom)+zimberelimab (zim)+chemotherapy (chemo) or zim+chemo followed by adjuvant dom+zim or zim in patients with resectable stage II-III non-small cell lung cancer (NSCLC).Journal of Clinical Oncology · 2024
19. Phase 1 study (DRAGON) of SRK-181 (linavonkibart), a latent TGFβ1 inhibitor, combined with pembrolizumab in patients with anti-PD1 resistant advanced solid tumors: Updated results of expansion part.Journal of Clinical Oncology · 2024
20. Analysis of hematology-oncology fellowship match outcomes (2007-2022) and cross-subspecialty comparisons: A retrospective cohort study.Journal of Clinical Oncology · 2024